Hangzhou Fuluo Biological Technology Co.,Ltd.
High quality, competitive price, fast delivery
Payment & Shipping Terms:
98% joint-supporting supplements Chondroitin sulfate sodium with EP standard
Chondroitin sulfate is used for osteoarthritis. It is often used in combination with other ingredients, including manganese ascorbate, glucosamine sulfate, glucosamine hydrochloride, or N-acetyl glucosamine.
Chondroitin sulfate is also taken by mouth for HIV/AIDS, heart disease, heart attack, weak bones (osteoporosis), joint pain caused by drugs used to treat breast cancer, acid reflux, high cholesterol, muscle soreness after exercise, a bladder condition called interstitial cystitis, a bone disease called Kashin-Beck disease, and itchy and scaly skin (psoriasis). Chondroitin sulfate is also used in a complex with iron for treating iron-deficiency anemia.
Chondroitin sulfate is available as an eye drop for dry eyes. In addition, it is used during cataract surgery, and as a solution for preserving corneas used for transplants. It is approved by the FDA for these uses.
Some people with osteoarthritis use ointments or skin creams for pain that contain chondroitin sulfate, in combination with glucosamine sulfate, shark cartilage, and camphor.
Some people also inject chondroitin sulfate into the muscles for osteoarthritis.
Some people insert chondroitin sulfate into the bladder for urinary tract infections (UTIs), bladder conditions, or loss of control of the bladder.
How does it work?
In osteoarthritis, the cartilage in the joints breaks down. Taking chondroitin sulfate, one of the building blocks of cartilage, might slow this breakdown.
800 mg to 1,200 mg daily in two to four divided doses. Often combined with glucosamine. Allow up to one month to notice effect.
The COA of Chondroitin sulfate:
|Product name||Chondroitin sulfate|
|CAS No.||9007-28-7||Outer Packing||25kgdrum|
|Production date||SJD20170317||Shelf life||Mar.16th, 2019|
|Standard adopted||Complied with EP4.0|
|Items of analysis||Specification||Results|
|Sodium Hyaluronate||≥ 98%||98.36%|
|Appearance of Solution||A600nm≤ 0.01||Complied|
|Nucleic Acid||A260nm≤ 0.5||Complied|
|Molecular Weight||2.5-3.5 Million Daltons||2.6 Million Daltons|
|Loss on drying||≤10%||6.00%|
|Residue on Ignition||≤20.00 %||10.85%|
|Molds & Yeast||≤10CFU/g||＜10CFU/G|
|Viable Hemolytical Streptococc||Negative||Negative|
|Bacterial Endotoxin||≤0.05IU/ mg||Complied|
|Shelf Life||Two Years|